Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jade Biosciences appointed Edward R. Conner, M.D., as Chief Medical Officer, granting him an inducement award of 500,000 stock options. The options have an exercise price of $25.38 per share, matching the April 22 closing price, and vest over four years.
Key figures
- Grant shares
- 500000
- Exercise price
- 25.38
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.